The event has surpassed our expectations on seniority and companies - this means the discussions are going to be much better and more meaningful in terms of change that benefits patients.
As it stands:
58% of attendees are at director level and above
62% of attendees are from big pharma.
Here is a selection of job titles and companies that are amongst the confirmed attendees for the first annual D4 event in Cambridge, MA.
Eli Lilly and Company
Alexion Pharmaceuticals, Inc
Klogene Therapeutics Inc.
Director, Genomic Biomarkers
Principal Research Investigator / NGS pipeline Lead
Global Area Head, Technical Solution Delivery & Architecture
Associate Director, Novel Capabilities & Knowledge Transformation
Associate Director, Partnership Office
Director of App Development - Digital Devices R&D
Global Safety Lead
Head Program and Portfolio Management
Global Head Innovation, LLC.
Senior Director Technology Strategy and Innovation
Director, Data Sciences
Medical Director, Inflammation and Immunology
Head of Computational Biology
Executive Director, Translational Science Oncology
VP, R&D, Global Operations and Global IT
Senior Director, Pharmacogenetics and Human Genetics